Safety and biologic activity of a bispecific T cell receptor targeting HIV Gag in males living with HIV: a first-in-human trial

Journal:

Nature Communications

Published:

2026-01-31

DOI:

10.1038/s41467-026-68833-2

Affiliations:

22

Authors:

28

Go to article

Institutions	Authors	Share
Immunocore, United Kingdom (UK)	12.000000 12.000000	0.43
Immunocore, LLC, United States of America (USA)	3.000000	0.11
Ghent University (UGent), Belgium	2.000000	0.07
NIHR Imperial Biomedical Research Centre, United Kingdom (UK)	2.000000	0.07
University Hospital, VUB, Belgium	1.000000	0.04
Chelsea and Westminster Hospital, Chelsea and Westminster Hospital NHS Foundation Trust, United Kingdom (UK)	1.000000	0.04
King's College Hospital NHS Foundation Trust, United Kingdom (UK)	1.000000	0.04
Biomedical Research Networking Center for Infectious Diseases (CIBERINFEC), Spain	0.700000	0.03
Guy's and St Thomas' NHS Foundation Trust, United Kingdom (UK)	0.500000	0.02
King's College London (KCL), United Kingdom (UK)	0.500000	0.02
Vall d'Hebron University Hospital (HUVH), ICS, Spain	0.500000	0.02
Vall d'Hebron Research Institute (VHIR), HUVH ICS, Spain	0.500000	0.02
North Manchester General Hospital, United Kingdom (UK)	0.500000	0.02
Manchester University NHS Foundation Trust (MFT), United Kingdom (UK)	0.500000	0.02
Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Spain	0.500000	0.02
Biomedical Research Networking Centers (CIBER), Spain	0.500000	0.02
Health Research Institute of San Carlos (IdISSC), Spain	0.500000	0.02
Institute for Health Science Research Germans Trias i Pujol (IGTP), HUGTP ICS, Spain	0.200000	0.01
Fight Infections Foundation, Spain	0.200000	0.01
Institute for AIDS Research (IrsiCaixa), Spain	0.200000	0.01
University of Vic - Central University of Catalonia (UVic-UCC), Spain	0.200000	0.01

Interested in Clinical Sciences?